The role of positron emission tomography in breast cancer: a short review

被引：5
|
作者：
Marino M.A. [1 ,2 ]
Helbich T.H. [1 ]
Blandino A. [2 ]
Pinker K. [1 ]
机构：
[1] Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18–20, Vienna
[2] Department of Biomedical Sciences and Morphologic and Functional Imaging, Policlinico G.Martino, University of Messina, Messina
来源：
memo - Magazine of European Medical Oncology | 2015年 / 8卷 / 2期
关键词：
18F-FDG; MAMMI-PET; PEM; PET/CT; PET/MRI;
D O I：
10.1007/s12254-015-0210-z
中图分类号：
学科分类号：
摘要：
Positron emission tomography (PET) provides information about abnormal metabolic features associated with cancer, and its role in breast cancer has been widely investigated. In the past several years, combined imaging systems, such as PET/CT and PET/MRI, and dedicated breast PET devices, such as PEM and MAMMI-PET, have been developed and implemented. These new techniques have become an effective oncologic tool for staging, re-staging, monitoring response to treatment, and estimation of the long-term prognosis. The aim of this review is to summarize the established and emerging PET imaging techniques and to discuss their value in the management of breast cancer patients. © 2015, Springer-Verlag Wien.
引用
收藏
页码：130 / 135
页数：5
相关论文
共 50 条
  • [41] Diagnostic value of positron emission tomography for detecting breast cancer
    Noh D.-Y.
    Yun I.-J.
    Kim J.-S.
    Kang H.-S.
    Lee D.-S.
    Chung J.-K.
    Lee M.C.
    Youn Y.-K.
    Oh S.K.
    Choe K.J.
    World Journal of Surgery, 1998, 22 (3) : 223 - 228
  • [42] Imaging mouse models of breast cancer with positron emission tomography
    S Cherry
    C Abbey
    S Borowsky
    J Gregg
    R Cardiff
    Breast Cancer Research, 5 (Suppl 1)
  • [43] FDG (18 fluorodeoxyglucose) : Positron emission tomography and breast cancer
    Menkès, MCJ
    Milhaud, MG
    Paolaggi, MJB
    de Gennes, MJL
    Picard, MJD
    Boulu, MR
    Nordmann, MR
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2005, 189 (05): : 975 - 978
  • [44] Cost-Effectiveness of Positron Emission Tomography in Breast Cancer
    J. Scott Sloka
    Peter D. Hollett
    Maria Mathews
    Molecular Imaging and Biology, 2005, 7 : 351 - 360
  • [45] Detection of Bone Metastases in Breast Cancer by Positron Emission Tomography
    Schirrmeister, Holger
    PET CLINICS, 2006, 1 (01) : 25 - 32
  • [46] A SHORT INTRODUCTION TO POSITRON EMISSION TOMOGRAPHY
    FRACKOWIAK, RSJ
    SEMINARS IN NEUROLOGY, 1989, 9 (04) : 275 - 280
  • [47] Positron emission tomography in breast cancer: a clinicopathological correlation of results
    Rostom, AY
    Powe, J
    Kandil, A
    Ezzat, A
    Bakheet, S
    El-Khwsky, F
    El-Hussainy, G
    Sorbris, R
    Sjoklint, O
    BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (863): : 1064 - 1068
  • [48] Positron Emission Tomography (PET) and breast cancer in clinical practice
    Lavayssiere, Robert
    Cabee, Anne-Elizabeth
    Filmont, Jean-Emmanuel
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 69 (01) : 50 - 58
  • [49] Flare phenomenon in positron emission tomography in a case of breast cancer-a pitfall of positron emission tomography imaging interpretation
    Tu, Dom-Gene
    Yao, Wei-Jen
    Chang, Tsai-Wang
    Chiu, Nan-Tsing
    Chen, Yi-Hsun
    CLINICAL IMAGING, 2009, 33 (06) : 468 - 470
  • [50] Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer
    Robson, Nicole
    Thekkinkattil, Dinesh Kumar
    MEDICINA-LITHUANIA, 2024, 60 (02):
12345